These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9060842)

  • 1. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.
    Marie PJ; de Pollak C; Chanson P; Lomri A
    Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating mutations of Gs protein in monostotic fibrous lesions of bone.
    Alman BA; Greel DA; Wolfe HJ
    J Orthop Res; 1996 Mar; 14(2):311-5. PubMed ID: 8648511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein.
    Motomura T; Kasayama S; Takagi M; Kurebayashi S; Matsui H; Hirose T; Miyashita Y; Yamauchi-Takihara K; Yamamoto T; Okada S; Kishimoto T
    J Bone Miner Res; 1998 Jul; 13(7):1084-91. PubMed ID: 9661072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
    Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
    J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.
    Yamamoto T; Ozono K; Kasayama S; Yoh K; Hiroshima K; Takagi M; Matsumoto S; Michigami T; Yamaoka K; Kishimoto T; Okada S
    J Clin Invest; 1996 Jul; 98(1):30-5. PubMed ID: 8690800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular and molecular biology of fibrous dysplasia].
    Marie P
    Ann Pathol; 2001 Dec; 21(6):489-98. PubMed ID: 11910936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
    Shenker A; Weinstein LS; Sweet DE; Spiegel AM
    J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
    Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
    N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
    Perdigão PF; Pimenta FJ; Castro WH; De Marco L; Gomez RS
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):498-501. PubMed ID: 15183415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
    Marie PJ; De Vernejoul MC; Lomri A
    J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular basis of fibrous dysplasia.
    Marie PJ
    Histol Histopathol; 2001 Jul; 16(3):981-8. PubMed ID: 11510989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
    Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
    J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions.
    Kashima TG; Nishiyama T; Shimazu K; Shimazaki M; Kii I; Grigoriadis AE; Fukayama M; Kudo A
    Hum Pathol; 2009 Feb; 40(2):226-37. PubMed ID: 18799196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrous dysplasia of bone and McCune-Albright syndrome.
    Chapurlat RD; Orcel P
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.
    Candeliere GA; Glorieux FH; Prud'homme J; St-Arnaud R
    N Engl J Med; 1995 Jun; 332(23):1546-51. PubMed ID: 7739708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopic studies of fibrous dysplasia.
    Ohira O
    Nihon Seikeigeka Gakkai Zasshi; 1981 May; 55(5):497-507. PubMed ID: 7288235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.
    Riminucci M; Fisher LW; Shenker A; Spiegel AM; Bianco P; Gehron Robey P
    Am J Pathol; 1997 Dec; 151(6):1587-600. PubMed ID: 9403710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of stem cells in fibrous dysplasia of bone and the Mccune-Albright syndrome.
    Robey PG; Kuznetsov S; Riminucci M; Bianco P
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():386-94. PubMed ID: 17982385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
    Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.